EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐ b ]pyridazine hybrid derivatives as VEGFR selective inhibitors

Shuang Wang, LinLing Gan, Lei Han, Ping Deng, Yihao Li, Dongxiao He, Haoze Chi, Liwei Zhu, Yuehui Li, Rui Long, Zongjie Gan

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Shuang Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, College of Pharmacy, Chongqing Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Pyridazines, Naphthalenes, Drug Design, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Chongqing Doctoral "Through Train" Scientific Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The vascular endothelial growth factor receptor (VEGFR) is a receptor tyrosine kinase that is regarded as an emerging target for abnormal angiogenesis diseases. In this study, novel naphthalene imidazo[1,2‐ b ]pyridazine hybrids as VEGFR selective inhibitors were designed and synthesized using a scaffold hopping strategy based on ponatinib, a multitarget kinase inhibitor. Among the evaluated compounds, derivative 9k (WS‐011) demonstrated the most potent inhibitory potency against VEGFR‐2 (IC 50 = 8.4 nM) and displayed superior VEGFR selectivity over a panel of 70 kinases compared with ponatinib. Furthermore, 9k possessed good cytotoxic effects on various cancer cell lines, especially the colon cancer HT‐29 cells, with an acceptable oral bioavailability. Moreover, 9k significantly inhibited the migration and invasion of human umbilical vein endothelial cells (HUVEC) cells and induced apoptosis through the upregulation of apoptotic proteins in HT‐29 cells. 9k also effectively suppressed the activation of VEGFR‐2 signaling pathways, which in turn inhibited the growth of HT‐29 cells and the tube formation of HUVECs in vitro. All of the findings revealed that 9k could be considered a promising antiangiogenesis lead that merits further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridazinesNaphthalenesDrug DesignProtein Kinase InhibitorsHuman Umbilical Vein Endothelial CellsApoptosisVascular Endothelial Growth Factor Receptor-2HumansStructure-Activity RelationshipHT29 CellsCell ProliferationMolecular StructureAntineoplastic AgentsCell MovementCell Line, TumorAngiogenesis InhibitorsDrug Screening Assays, AntitumorDose-Response Relationship, DrugImidazolesReceptors, Vascular Endothelial Growth Factor

Stichwörter der Autor:innen

VEGFR selective inhibitorsantitumornaphthaleneponatinib

Substanzen

PyridazinesNaphthalenesProtein Kinase InhibitorsVascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsAngiogenesis InhibitorsKDR protein, humanImidazolesReceptors, Vascular Endothelial Growth Factor

Autor:innen und Institutionen

  • Department of Medicinal Chemistry, College of Pharmacy, Chongqing Medical University, Chongqing, People's Republic of China.
  • Chongqing Engineering Research Center of Pharmaceutical Sciences, School of Pharmacy, Chongqing Medical and Pharmaceutical College, Chongqing, People's Republic of China.
  • Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Chongqing
  • Chongqing Doctoral "Through Train" Scientific Research Program
  • CQMU Program for Youth Innovation in Future Medicine

Zitieren

APA

Wang, S., Gan, L., Han, L., Deng, P., Li, Y., He, D., Chi, H., Zhu, L., Li, Y., Long, R., & Gan, Z. (2024). Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐ b ]pyridazine hybrid derivatives as VEGFR selective inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400411

Vancouver

Wang S, Gan L, Han L, Deng P, Li Y, He D, et al. Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐ b ]pyridazine hybrid derivatives as VEGFR selective inhibitors. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400411

BibTeX
@article{Wang2024,
  author = {Wang, Shuang and Gan, LinLing and Han, Lei and Deng, Ping and Li, Yihao and He, Dongxiao and Chi, Haoze and Zhu, Liwei and Li, Yuehui and Long, Rui and Gan, Zongjie},
  title = {Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐ b ]pyridazine hybrid derivatives as VEGFR selective inhibitors},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400411}
}
Kostenlos starten →